What You Should Know
- Extended reality (XR) clinical innovator XRHealth has announced the formal acquisition of digital therapeutics pioneer Swing Therapeutics, making it the largest multi-device XR digital health platform for chronic conditions.
- The transaction absorbs Swing’s flagship Stanza program, the first FDA De Novo–authorized prescription digital behavioral therapeutic indicated for the treatment of fibromyalgia symptoms, which impact 10 million Americans.
- Validated by a Phase 3 randomized controlled trial published in The Lancet, the Stanza protocol utilizes Acceptance and Commitment Therapy (ACT) to drive statistically significant reductions in chronic pain intensity, fatigue, and depression.
- The deal also integrates Swing Care, a multidisciplinary virtual specialty clinic led by global fibromyalgia authority Dr. Andrea Chadwick, which unifies behavioral digital software with physician-monitored medication management.
- Operating a fully covered model, the combined infrastructure deploys across VR glasses, smartphones, and wearables to deliver continuous, personalized whole-patient care reimbursed via Medicare Part B, VA programs, and commercial insurance pathways.
Technical Integration: Programming Whole-Patient Care via Stanza
The core product differentiation securing XRHealth’s market expansion moves entirely away from un-monitored consumer health widgets to enforce a rigid, clinically validated model of software-driven intervention. Central to the acquisition is Swing’s Stanza® program, a highly structured prescription digital therapeutic that has secured prestigious FDA De Novo authorization for the treatment of fibromyalgia symptoms. Impacting over 10 million individuals across the United States, fibromyalgia has historically remained one of the most underserved and poorly managed chronic pain conditions in the medical sector.
Grounded in the psychological parameters of Acceptance and Commitment Therapy (ACT), Stanza’s clinical efficacy is backed by a rigorous Phase 3 randomized controlled trial published in The Lancet. The data documents substantial, reproducible improvements across fibromyalgia severity, sleep disruption, chronic fatigue, and depression.
Within the integrated XRHealth software ecosystem, this software platform interfaces directly with active clinician workflows:
- Multi-Modal Signal Ingestion: Patients engage with their therapeutic protocols across immersive virtual reality environments and mobile applications, allowing the platform to reason about physical and behavioral responses simultaneously.
- Continuous Physician Monitoring: Licensed physicians and clinical specialists actively review real-time telemetry datasets, adjusting medication management and coaching lines dynamically as the patient’s condition evolves.
- Closed-Loop Data Tracking: Algorithmic backend pipelines synthesize patient outcomes data into automated, scannable progress charts, stripping away clerical reporting noise for the treating practitioner.
“The future of therapeutic care is technology. Not as a supplement to medicine, but as the medicine itself—delivered through AI, monitored by licensed clinicians, reimbursed by insurance, and continuously improved by outcomes data,” stated Eran Orr, CEO of XRHealth. “XRHealth and Swing Therapeutics together represent the most comprehensive approach to this challenge ever assembled—spanning devices, apps, digital therapeutics, clinical care, and peer support, all in one platform.”
Proving the Return on Outcomes: Reimbursable Virtual Clinics
The primary commercial differentiator driving the expansion of this combined network is its deep alignment with existing federal and commercial reimbursement pathways. Major multi-hospital groups face intense staffing constraints, making them highly resistant to adopting external software tools that require complex internal technical assembly. XRHealth directly solves this procurement friction by operating as an approved, licensed virtual clinic across 22 U.S. states.
Crucially, because the platform delivers its continuous, evidence-based care programs through Medicare Part B, Veterans Affairs (VA) programs, and expanding commercial insurance pipelines, the infrastructure completely eliminates upfront commercial procurement drag for partnering health systems.
This structural reimbursement model is supported by exceptional real-world outcomes data collected at the one-year mark of Swing Care’s virtual operations. Under the clinical guidance of Medical Director Dr. Andrea Chadwick, a globally recognized expert in fibromyalgia care, 88.0% of patients reported a statistically significant improvement in their overall wellbeing on the Patient Global Impression of Change (PGIC) scale, with more than half (50.2%) stating they felt “much improved” or better. By providing an objective, data-grounded system of record that unifies advanced software design with live clinical oversight, the platform provides a repeatable blueprint for sustainable chronic care delivery.
